Vaccinex

VCNX · OTC

$0.7001−$0.2999 (−29.99%)TodayMarket closed · Oct 20, 2:14 PM ET

No price history for this range.

About VCNX

Vaccinex, Inc. operates as a clinical-stage biotechnology company. The company is headquartered in Rochester, New York and currently employs 23 full-time employees. The company went IPO on 2018-08-09. The firm is engaged in the discovery and development of targeted biotherapeutics to treat serious diseases and conditions with unmet medical needs, including neurodegenerative diseases, cancer, and autoimmune disorders. Its lead product candidate, pepinemab, is in clinical development for the treatment of Alzheimer’s disease, head and neck, pancreatic and breast cancer. Its platform technologies include SEMA4D antibody platform and ActivMAb antibody discovery platform. Its SEMA4D antibody platform is the application of its knowledge of SEMA4D biology to develop pepinemab for the treatment of various diseases and conditions, including neuroinflammatory and neurodegenerative diseases and cancer. The company also discovered VX5 using its ActivMAb platform. VX5 is a human antibody to CXCL13, a molecule that regulates the formation of immune tissues, and is in preclinical development for the treatment of autoimmune disorders.

Employees: 23
Headquarters: Rochester, New York
Listed: Aug 9, 2018
Sector: Health Care
Industry: Biotechnology
Website: vaccinex.com

Leadership

Vaccinex executives
Name	Title	Since	Age
Albert Friedberg	—	2001	79
Maurice Zauderer	—	2001	79
Jill Sanchez	—	—	53
Elizabeth Evans	—	—	53
Ernest Smith	—	—	53
Jacob Frieberg	—	—	68
Michael Rice	—	2022	—

Suppliers and customers

Price correlation is over one year: 1 means the stocks move together, -1 opposite

Vaccinex suppliers and customers
Company	Relationship	Country	Correlation
Surface Oncology Rg SURF	Supplier and customer	US	0.77
Biocon	Supplier and customer	IN	0.50
Catalent CTLT	Supplier and customer	US	0.46
Merck MRK.DE	Supplier and customer	DE	-0.22
Merck & Co MRK	Supplier and customer	US	-0.40
Huntington Study Group	Supplier	US	—
University of Rochester	Supplier and customer	US	—
Children's Hospital of Philadelphia	Supplier and customer	US	—
EMORY UNIVERSITY	Supplier and customer	US	—
University of California, Los Angeles	Supplier and customer	US	—

Similar companies

Companies in the same industry as Vaccinex

Information on this page is provided for informational purposes only and is not a recommendation to buy, sell or hold any security. Investing involves risk, including possible loss of principal. Market data is delayed at least 15 minutes and is provided without warranty. Analyst ratings, price targets and company data come from third-party sources. Past performance does not guarantee future results.